Peter Sillevis Smitt Selected Research

ErbB Receptors (EGF Receptor)

5/2015

Mutation specific functions of EGFR result in a mutation-specific downstream pathway activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Sillevis Smitt Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 05/2015
3	Paraneoplastic Cerebellar Degeneration 06/2012 - 06/2003
2	Hodgkin Disease (Hodgkin's Disease) 06/2012 - 05/2010
2	Cerebellar Ataxia (Dysmetria) 05/2010 - 06/2003
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Cerebellar Diseases (Cerebellar Syndrome) 12/2020
1	Encephalitis (Encephalitis, Rasmussen) 12/2020
1	Neurologic Manifestations (Neurological Manifestations) 12/2020
1	Dementia (Dementias) 12/2015
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 12/2015
1	Autoimmune Diseases of the Nervous System 12/2015
1	Ataxia (Dyssynergia) 05/2010
1	Autoimmune Diseases (Autoimmune Disease) 05/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2006

Drug/Important Bio-Agent (IBA)

5	AntibodiesIBA 01/2021 - 06/2003
2	metabotropic glutamate receptor type 1IBA 12/2020 - 05/2010
2	AntigensIBA 12/2015 - 06/2012
2	AutoantibodiesIBA 06/2012 - 05/2010
1	N 30IBA 12/2020
1	Immunoglobulin G (IgG)IBA 12/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2020
1	Tyrosine Kinase InhibitorsIBA 06/2020
1	ErbB Receptors (EGF Receptor)IBA 05/2015
1	Epidermal Growth Factor (EGF)IBA 06/2012
1	Rituximab (Mabthera)FDA Link 01/2006
1	Monoclonal AntibodiesIBA 01/2006

Therapy/Procedure

1	Therapeutics 05/2010